1 Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital, LMU Munich, Germany.
2 Psychiatrist&Clinical Pharmacologist, Chief Principal Investigator PSY-PGx. Department of Psychiatry, Parnassia Psychiatric Institute, Amsterdam, the Netherlands; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; St John's National Academy of Health Sciences, Bangalore, India. Electronic address: r.vanwestrhenen@psyq.nl.